| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA996383929903316 |
|
|
Autore |
French John <1616-1657.> |
|
|
Titolo |
The art of distillation, or A treatise of the choisest spagyricall preparations performed by way of distillation [[electronic resource] ] : being partly taken out of the most select chymicall authors of severall languages, and partly out of the authors manuall experience; together with the description of the chiefest furnaces and vessels used by ancient, and moderne chymists: also, a discourse of divers spagyrical experiments and curiosities, and of the anatomy of gold and silver with the chiefest preparations, and curiosities thereof, and vertues of them all. / / All which are contained in six books, composed by John French, Dr. of Physick |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
London, : Printed by Richard Cotes and are to be sold by Thomas Williams at the Bible in Little-Britain without Aldersgate, 1651 |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
[24], 199, [17] p. : ill. (woodcuts) |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Title page in red and black. |
With eight final contents leaves. |
Annotation on Thomason copy: "Dec: 7th 1650", the 51 in imprint the date crossed out. |
Reproduction of the original in the British Library. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910437849203321 |
|
|
Titolo |
Sendai Virus Vector : Advantages and Applications / / edited by Yoshiyuki Nagai |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Tokyo : , : Springer Japan : , : Imprint : Springer, , 2013 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed. 2013.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (218 p.) |
|
|
|
|
|
|
Disciplina |
|
611.01816 |
616.9 |
616.9/101 |
616.9101 |
|
|
|
|
|
|
|
|
Soggetti |
|
Virology |
Gene therapy |
Gene expression |
Gene Therapy |
Gene Expression |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references at the end of each chapters and index. |
|
|
|
|
|
|
|
|
Nota di contenuto |
|
1. Reverse genetics of Mononegavirales: the rabies virus paradigm Karl-Klaus Conzelmann -- 2. Sendai virus biology and engineering leading up to the development of a novel class of expression vector Yoshiyuki Nagai and Atsushi Kato -- 3. Concept and technology underlying Sendai virus (SeV) vector development Akihiro Iida and Makoto Inoue -- 4. Roadmap for development of a replication-deficient Sendai virus vaccine vector (provisional) Marian Wiegand and Wolfgang Neubert -- 5. Development of vaccines using SeV vectors against AIDS and other infectious diseases Sayuri Seki and Tetsuro Matano -- 6. BioKnife, a modified Sendai virus, to resect malignant tumors Yoshikazu Yonemitsu, Yasuji Ueda and Mamoru Hasegawa -- 7. Induction of human pluripotent stem cells by the Sendai virus vector:Establishment of a highly efficient and foot-print free system Noemi Fusaki and Hiroshi Ban -- 8. Gene therapy for peripheral arterial disease using Sendai virus vector: From preclinical Studies to |
|
|
|
|
|
|
|
|
|
|
|
the phase I/IIa clinical trial Yoshikazu Yonemitsu, Takuya Matsumoto and Yoshihiko Maehara. |
|
|
|
|
|
|
Sommario/riassunto |
|
Sendai virus (SeV) is not just a mouse pathogen but is evolving into a cutting-edge component of biotechnology. SeV reverse genetics originating from a pure academic need to settle long-held questions in the biology and pathogenicity of nonsegmented negative strand RNA viruses (Mononegavirales) is about to bear the impressive fruit of multipurpose cytoplasmic (non-integrating) RNA vectors. This book brings together in one source the SeV biology revealed by conventional approaches and reverse genetics, the methods to construct the first-generation SeV vector and to generate safer versions, and the applications in medical settings that have left or are about to leave the laboratory bench. The applications, which already are diverse and have high medical impact, include use as vaccine vectors against AIDS and respiratory virus infections, creation of BioKnife to resect malignant tumors, induction of “footprint (transgene) free” pluripotent stem cells, and gene therapy for peripheral arterial disease. These achievements—which are just a few of many examples—were attainable only after rigorously incorporating the rich knowledge of SeV biology that has accumulated during the several decades since the discovery of the virus. Application of SeV vector is certain to expand greatly because of its extremely high performance in transgene expression and its remarkable target cell breadth. |
|
|
|
|
|
|
|
| |